Key Takeaways
Chevron (CVX) reports Q4 earnings on January 30, with consensus EPS of $1.53–$1.54 on $52.7 billion in revenue. Results reflect record production from Hess assets and the Permian Basin.
ExxonMobil (XOM) also reports on January 30, with expectations of $1.65 EPS on $82.85 billion in revenue, supported by strong output from Guyana and the Permian.
Shell (SHEL) reports on February 5, with EPS forecast around $1.26. Q3 adjusted earnings reached $5.4 billion, driven by upstream and LNG strength.
All three energy majors face softer oil prices but benefit from production growth; refining margins and 2026 cash flow guidance will be key focus areas.
Chevron targets $12.5 billion in incremental free cash flow by 2026 through Hess synergies and cost reductions.
Why This Comparison Matters
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
ExxonMobil continues to scale low-cost production in Guyana and the Permian Basin, closely mirroring Chevron’s upstream-driven growth. Shell, by contrast, leans more heavily on LNG and gas, offering diversification amid refining and chemicals margin pressure. Investors are watching volume growth, capital discipline, and medium-term guidance as geopolitical risks, OPEC+ supply decisions, and energy transition investments remain in focus.
Chevron (CVX): Earnings Preview
Chevron is expected to post adjusted Q4 EPS of $1.53–$1.54, down roughly 25% year over year, on revenue of $52.7 billion, slightly higher than last year. Lower Brent crude prices weigh on results, but increased volumes from Hess and operational efficiencies in the Permian provide partial offsets.
In Q3, Chevron delivered an EPS beat of $1.85 on $49.73 billion in revenue, supported by a 21% year-over-year jump in production. Hess contributed approximately 495,000 boe/d, while U.S. output continued to rise. Management’s focus remains on maintaining Permian production near 1 million boe/d, improving downstream margins, and executing on cost-saving initiatives.
Key themes include $3–4 billion in structural cost reductions by 2026, incremental free cash flow of $12.5 billion, and annual capex guidance of $17–17.5 billion. Chevron has beaten earnings estimates in three of the past four quarters, with modest positive stock reactions typically tied to production surprises.
ExxonMobil (XOM): Earnings Preview
ExxonMobil reports Q4 results alongside Chevron on January 30. Consensus expectations call for $1.65 EPS on $82.85 billion in revenue, reflecting slightly lower sales but stable profitability year over year.
The company’s Q3 results exceeded expectations with $1.88 EPS on $85.29 billion in revenue, driven by record production in Guyana (700,000 barrels per day) and Permian output of 1.7 MMboe/d. Refining margins remained supportive, though chemicals continued to lag.
Exxon generated $14.8 billion in operating cash flow and returned $9.4 billion to shareholders in Q3. Its long-term strategy centers on $27–29 billion in annual capex through 2026, targeting $25 billion in earnings growth versus 2024 at $65 Brent crude. Strong balance sheet metrics and a deep inventory of low-cost projects position Exxon favorably versus peers.
Shell (SHEL): Earnings Preview
Shell reports Q4 earnings on February 5, with EPS expected near $1.26. Trading updates suggest the Chemicals & Products segment may approach break-even, while marketing results could be pressured by seasonal tax effects.
In Q3, Shell delivered $5.4 billion in adjusted earnings on $68.15 billion in revenue and generated $12.2 billion in operating cash flow. Upstream production reached records in Brazil and the Gulf of Mexico, while LNG volumes rose 8% quarter over quarter.
Recent asset sales, including the Colonial Pipeline stake, generated roughly $1 billion, supporting a $3.5 billion share buyback. Shell’s gas-heavy portfolio helps cushion oil price weakness, though refining and chemicals remain sensitive to margin volatility. Management continues to emphasize capital discipline, with 2025 capex guidance of $20–22 billion.
Head-to-Head Comparison
Production growth: Chevron leads on percentage growth, while Exxon dominates on absolute scale. Shell offers diversification through LNG.
Earnings quality: All three beat Q3 estimates, but Q4 EPS expectations reflect softer oil prices. Low breakeven costs in the Permian benefit CVX and XOM, while Shell’s downstream exposure adds risk.
Balance sheet and cash flow: Exxon holds an edge with strong debt metrics and consistent shareholder returns.
Key risks: Chevron faces integration and geopolitical exposure, Exxon remains exposed to chemicals, and Shell is sensitive to refining margins and energy transition spending.
AI-Based Trading Perspective
Tickeron offers AI-driven trading tools for all three stocks. Chevron and Exxon are supported by short-term corridor-based strategies designed for range-bound markets, while Shell aligns with a trend-following large-cap strategy. These systems are designed to manage volatility around earnings events and improve risk-adjusted entries.
View CVX bot. XOM's counterpart uses identical corridor logic for short-term trades. View XOM bot. SHEL aligns with the Trend Trader for Beginners (60min TA), capturing large-cap trends.View SHEL strategy.
Bottom Line
From a comparative standpoint, ExxonMobil stands out for scale, balance sheet strength, and consistent execution, particularly at moderate oil prices. Chevron offers upside tied to Hess synergies and production growth, while Shell may appeal to investors bullish on LNG and gas markets. As always, outcomes hinge on commodity prices, margins, and forward guidance rather than headline earnings alone.
Disclaimers and Limitations
CVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 18 of 28 cases where CVX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 64%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 52 cases where CVX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on CVX as a result. In 55 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVX advanced for three days, in 239 of 385 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 195 of 348 cases where CVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
The 10-day RSI Indicator for CVX moved out of overbought territory on September 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 19 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Moving Average Convergence Divergence Histogram (MACD) for CVX turned negative on September 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 22 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 42%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 40%.
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.132) is normal, around the industry mean (1.887). P/E Ratio (19.862) is within average values for comparable stocks, (16.521). Projected Growth (PEG Ratio) (0.903) is also within normal values, averaging (1.088). Dividend Yield (0.034) settles around the average of (0.035) among similar stocks. P/S Ratio (2.004) is also within normal values, averaging (3.764).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which explores and refines oil and natural gas
Industry IntegratedOil